The role of local surgical procedures in patients with metastatic soft tissue sarcoma is still undefined. Few retrospective studies have reported survival benefits for patients with pulmonary metastases after complete surgical resection. Treatment decisions are therefore mainly based on personal experiences rather than on reproducible knowledge.
neoplasms. 1 Early hematogenic metastases is a typical feature of high-grade STS. The most common localization of synchronous and metachronous metastatic disease is the lung. 2 This fact leads to selection bias in clinical trials and retrospective analyses by merely and exclusively focusing on metastatic STS to the lung. To the best of our knowledge, no dedicated study has analyzed the importance of local surgical procedures according to different metastatic sites.
Metastatic STS is generally considered incurable. Due to limited systemic treatment options for the majority of patients, complete surgical resection may be the most efficient therapy for achieving long-term responses or even cure in selected cases. 3 Some retrospective analyses have revealed that resection of lung metastases may be accompanied by a longer chemotherapy-free interval, a longer progression-free interval (PFI), or even an improved overall survival (OS). [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] However, the benefit from local surgical procedures in individual cases remains unclear.
The aim of this study was to retrospectively analyze the database of the South-West German Cancer Center at the University of Tuebingen in order to establish prognostic and predictive factors associated with metastasectomies at different anatomic locations.
| PATIENTS AND METHODS

| Legal requirements
Ethics approval for the retrospective data analysis was obtained from the faculty of the Eberhard-Karls-University and the University Hospital Tuebingen Ethics Committee (Project Number: 582-2015-BO2).
| Patients
All patients diagnosed with STS, who underwent any surgical procedure from October 1982 to October 2015 at the University Hospital Tuebingen were screened. The patient selection method followed the "Gießener Tumordokumentationssystem" (GTDS)-an 
| Prognostic variables
An analysis of potentially prognostic variables that may influence the OS of metastatic sarcoma patients was conducted, which included the following: (1) Patient demographics (gender and age at diagnosis);
(2) factors related to primary tumor (histological subtype, anatomical site, resection of the primary tumor, location of primary histological diagnosis, histological grade, and tumor size); (3) metastatic pattern (time of occurrence of metastases, location and number of metastases at first occurrence); (4) treatment of metastases (resection at first occurrence of metastases, number of metastasectomies, surgeries according to number of metastases, number of pulmonary resections performed for metastases, applied technique for the resection of lung metastases, type of lung resection); (5) course of disease (existence of a local relapse before metastases, PFI until date of the first recurrence);
(6) first-line therapy (surgery only, surgery and radiotherapy, surgery and radiochemotherapy, surgery and chemotherapy). 
| Statistical analysis
| RESULTS
| Patients
According to the pre-defined searching criteria, 237 patients were included in the retrospective analysis. Five patients (2.1%) did not develop sarcoma. Therefore, reference pathology was performed for 160 patients (67.5%). It revealed one misdiagnosis of sarcoma (0.4%). Overall, 25 patients (10.6%) did not undergo resection of metastases and 32 patients (13.5%) showed non-adult STS histology (osteosarcoma, n = 11, Ewing's sarcoma, n = 9, GIST, n = 7, chondrosarcoma, n = 5) and were excluded from the analysis. Finally, a total of 102 patients (43.0%) with metastatic STS were included in the planned study ( Figure 1 ).
| Reference pathology of the 102 patients
Unfortunately, no tumor material could be obtained for histological reference from 26 patients (25.5%) because the period of retention for their cases exceeded 10 years and tumor material was therefore disposed in these particular cases. Of the remaining 76 patients (74.5%), nine (8.9%) showed a change in the sarcoma entity and 14 (13.7%) showed a change in the histological grade after reference pathology; three of these patients (2.9%) showed a change in the tumor entity as well as in the histological grade.
| Distribution of patients according to the histological subtype of the primary tumor
STS patients were re-categorized as per the 7th edition of TNM classification. Almost all histological variants of STS were represented among the patients with metastatic diseases. The most common subtype was leiomyosarcoma with 32 patients (31.4%), followed by 15 patients (14.7%) with pleomorphic sarcoma, 12 patients (11.8%) with synovial sarcoma, and nine patients (8.8%) with liposarcoma. A total of 34 patients (33.3%) were pooled in the "others" group, which comprised of a small sample size of different individual subtypes (Table 1 ).
| Prognostic factors
| Demographic data
The median age of the 102 patients at primary diagnosis was 47 years (age range: 19-85). 42 were males (41.2%; median age: 49 years, range 19-78) and 60 were females (58.8%; median age: 47 years, range 23-85).
| Characterization of the primary tumor
The histological subtypes of the remaining 102 patients are listed in Table 1 . The most common anatomical primary site was the trunk (46 of 102 patients, 45.1%), followed by the uterus (22/21.6%), lower extremities (21/20.6%), and other sites (13/12.7%), which included upper extremities (7/6.8%) and the head and neck region The initial unilocular cases occurred in the lungs in 44 patients (43.1%) and in other organs in 28 cases (27.5%), which included the bones (n = 7; 6.9%), abdomen (n = 7; 6.9%), liver (n = 3; 2.9%), thorax (n = 2; 1.9%), lymph nodes (n = 1; 1.0%), CNS (n = 1; 1.0%), and other organs (n = 7; 6.9%).
The number of metastases at the time of first occurrence was documented in 73 cases (71.6%), of which 43 patients (42.2%) were presented with 1-4 metastases (oligometastasized), including single metastases (n = 29; 28.5%), two metastases (n = 10; 9.8%), three metastases (n = 3; 2.9%), and four metastases (n = 1; 1.0%). 30 patients (29.4%) presented with >4 metastases. In the univariate analysis, age, resection of primary tumor, histological grade, time-point of metastasization, surgery at the first occurrence of distant metastases, the number of metastasectomies, and the PFS were associated with prolonged OS ( Table 2 ). In the multivariate analysis, only the resection of primary tumor, time-point of metastasization, number of metastasectomies, and PFS remained significant ( Table 3) . 
| Treatment of metastases
| Prognostic factors of metastatic patients with STS
| Recursive partitioning analysis
Recursive partitioning analysis was calculated using significant prognostic factors from multivariate analysis, for which a decision tree was subsequently created (Figure 3 ). The three terminal nodes were identified based on PFI and the number of metastasectomies.
Three prognostic groups were formed based on the median survival (Figure 4 ).
| Detailed analysis of long-term survivors
In this analysis, a remarkable number of patients (n = 15) with metastatic diseases survived for ≥10 years (14.7%). A detailed analysis was performed according to similar prognostic factors applied to the entire population of metastatic patients with STS ( Supplementary Table S1 ). The Fisher's exact test for univariate analysis revealed a significant correlation with a better OS for the number of metastasectomies (P = 0.004) and PFI (P = 0.009) in the group of long-term survivors versus patients who survived for <10 years ( Supplementary Figures S1 and S2 ). In the binary logistic regression for multivariate analysis, the number of metastasectomies (P = 0.013, OR = 0.134) and PFI (P = 0.011, OR = 0.128) remained significant ( Supplementary Table S2 ). The median OS of the longterm survivors who underwent >1 metastasectomy and had a PFI of >12 months could not be determined because of the large number of patients (n = 9; 60.0%) who remained alive. The median OS of patients who survived for <10 years and had only undergone one metastasectomy was 39 month and 32 month for those who survived <10 years and had a PFI of≤ 12 month.
| DISCUSSION
The overall poor prognosis and still unfavorable course of disease under medical treatment require application of multimodal therapeutic strategies for patients with metastatic STS. 18 The aim of the present study was to retrospectively analyze the impact of local surgical procedures on the OS of patients with metastatic adult-type STS.
After a median observation time of 118 months, the median OS of the finally analyzed cohort of 102 STS patients was 64 months, with 3-, 5-, 10-, and 20-year survival rates of 70.7%, 50.3%, 24.7%, and 14.8%, respectively. This compares very favorably to other historical reports. 19 The data suggest that the development of a highly specialized center aimed at the long-term survival for STS patients, including even those with metastatic disease, is achievable.
In contrast to previously published reports, we have herein also looked at surgical removal of metastases from non-pulmonary sites. [4] [5] [6] [10] [11] [12] [13] [14] [15] [16] [17] Neither occurrence of metastases at non-pulmonary localizations, nor the number of pulmonary resections or the technical procedure of lung surgery showed any statistical significance with regard to the OS. However, repeated surgery of metastatic disease of any localization emerged as a significant prognostic factor for OS, which has been shown for repeated resection of pulmonary metastases. 4, 5, 11, 15, 17 Indeed, the median OS for patients who underwent only one result is in line with other published reports. 4, [12] [13] [14] 17 Although different studies reported conflicting conclusions, 8,10-11 the result of the present analysis highlighted the high significance in univariate and multivariate analyses. Again, patients presenting with a PFI of ≥12 months after a prior treatment may suffer from biologically less aggressive disease, but this notion may help in the decision-making process for repeated surgeries in the future.
The time-point of metastatic spread was prognostic in both univariate and multivariate analysis with a median OS of 67 versus 39 months in patients with metachronous versus synchronous metastasis. The sample size of 24 patients with synchronous metastasis may be relatively small, but is still comparably higher than in previously published studies, where the time-point of metastatic spread was not found to be prognostic. 12, 15 The exceptionally unfavorable prognosis of the three patients, whose primary tumor had not been removed is very plausibly due to their initially advanced disease and not due to the fact that their primary tumor was not resected.
Other variables such as age, histological grade, or resection of metastases at the time-point of occurrence of the first distant metastases, which were identified as prognostic in other reports, [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] were found to be significant in the univariate, but not in the multivariate analysis in this study. Owing to the rareness of the disease and lack of funds in its research, future prospective analyses are not expected.
Nevertheless, a pooled analysis using data from international centers may deliver a basis for a valid statistical evaluation.
Analysis of other factors such as histological subtypes, tumor size, the number of metastases, or different forms of therapy applied was not statistically significant in the current analysis with regard to the OS for both univariate and multivariate analyses. Again, the sample size may be a limiting factor.
FIGURE 3
Recursive partitioning analysis decision tree. Three terminal nodes with three groups were identified from significant prognostic factors of multivariate analysis and based on the median survival time: Group A: patients with a PFI of < -12 months (1 or >1 metastasectomy) (node 1); Group B: patients with a PFI of ≥12 months and 1 metastasectomy; Group C: patients with a PFI of ≥12 months and >1 metastasectomy
The Kaplan-Meier curves of the three prognostic groups derived from recursive partitioning analysis. Log-Rank test revealed significant differences among the three groups
Because of the peculiar biology of oligometastatic disease, several authors have suggested that surgery may especially beneficial in this selected patient population. 4, 5, [20] [21] [22] We found no significant survival effect, when probability of survival for patients with oligometastatic versus polymetastatic disease were compared, which is line with most previously published reports. 4, 10, 13, 15, 17 Only two studies demonstrated a survival benefit for patients with a limited number of metastases. 23, 24 However, in the third analysis performed by the same research group, a few years later, these results were relativized. 25 In order to create a clinically relevant decision tree, a recursive partitioning analysis was performed. This approach allowed linking of complex non-linear relationships to the endpoint. By the stepwise splitting of the independent prognostic variables, patients were appropriately grouped according to their characteristics. 26 Kang et al. 17 initially adopted this approach for a survival analysis of patients with metastatic STS. 17 The results of the present analysis considered two factors for grouping patients: 1) PFI and 2) the number of metastasectomies.
For the resection of the primary tumor and the assessing time- The present analysis has some limitations that should be considered while interpreting the results, which are as follows: 1)
the retrospective character of the study demands attention on data quality, missing data, and information; 2) sarcoma is a very rare and heterogeneous disease. Therefore, only a small group of patients with metastatic STS was found to be suitable for analysis and they were studied over a very long period of time. The analyzed data should therefore be validated in a multicentric, national, or international setting. Alternatively, a pooled analysis can be considered; 3) due to the small sample sizes, the current analysis included all histological subtypes. Therefore, a stratification regarding treatment strategy for specific histological subtypes was not feasible; 4) during the long time period of data collection, repeated changes occurred in the therapeutic strategies as well as with the releases of new drugs, which altogether significantly influenced the patient prognosis. 27
| CONCLUSION
This study aimed at evaluating the role of surgical procedures in patients with metastatic STS. Different statistical models and subgroup analyses of long-term survivors confirmed that the PFI and repeated surgery of metastases are significant prognostic variables that are statistically relevant for the survival benefit of these patients. Importantly, this finding applies not only for patients with pulmonary metastases but also for those with metastases of any other localization. As long as the technical requirements are met, an adequate health status is maintained and informed consent is obtained, resection of metastases demonstrates an effective therapeutic option for a significant survival benefit at the time of primary diagnosis, as well as for recurrent occurrence. Notably, longterm survival of ≥10 years was achieved in a significant proportion of patients. The PFI after prior treatments should be considered as a decision support for repeated resection of metastases.
Fortunately, for some of the long-term survivors in the current analysis, disease activity was not evident for several years after treatment, which confirms that curing metastatic disease by repeated resections of metastases may be feasible in selected cases.
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